Chronic and episodic migraine studies are often complex. For one, rescue medications, migraine incidence, and the associated symptoms need to be carefully tracked. Patients may have innate expectations of the clinical trial, causing physiological effects on their underlying condition that could ultimately affect the study. Finally, migraine patients experience debilitating pain and symptoms, making participating in a clinical trial difficult. That’s where Signant Health’s solutions can help.
